133 related articles for article (PubMed ID: 32758590)
1. Novel Drosophila model for parkinsonism by targeting phosphoglycerate kinase.
Shimizu J; Kasai T; Yoshida H; Huynh AM; Nakao-Azuma Y; Shinomoto M; Tokuda T; Mizuno T; Yamaguchi M
Neurochem Int; 2020 Oct; 139():104816. PubMed ID: 32758590
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Nrdp1 toxicity by Parkin in Drosophila models.
Tan Y; Yu F; Pereira A; Morin P; Zhou J
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):18-23. PubMed ID: 22086177
[TBL] [Abstract][Full Text] [Related]
3. A neuroprotective role of the human uncoupling protein 2 (hUCP2) in a Drosophila Parkinson's disease model.
Islam R; Yang L; Sah M; Kannan K; Anamani D; Vijayan C; Kwok J; Cantino ME; Beal MF; Fridell YW
Neurobiol Dis; 2012 Apr; 46(1):137-46. PubMed ID: 22266335
[TBL] [Abstract][Full Text] [Related]
4. The Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.
M'Angale PG; Staveley BE
BMC Neurosci; 2016 May; 17(1):24. PubMed ID: 27192974
[TBL] [Abstract][Full Text] [Related]
5. Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
Quintero-Espinosa D; Jimenez-Del-Rio M; Velez-Pardo C
Brain Res; 2017 Feb; 1657():253-261. PubMed ID: 28041945
[TBL] [Abstract][Full Text] [Related]
6. Myopathy and parkinsonism in phosphoglycerate kinase deficiency.
Sotiriou E; Greene P; Krishna S; Hirano M; DiMauro S
Muscle Nerve; 2010 May; 41(5):707-10. PubMed ID: 20151463
[TBL] [Abstract][Full Text] [Related]
7. Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity.
Lin CH; Lin HI; Chen ML; Lai TT; Cao LP; Farrer MJ; Wu RM; Chien CT
Hum Mol Genet; 2016 May; 25(10):1965-1978. PubMed ID: 26931464
[TBL] [Abstract][Full Text] [Related]
8. Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson's Disease.
Tran HH; Dang SNA; Nguyen TT; Huynh AM; Dao LM; Kamei K; Yamaguchi M; Dang TTP
Sci Rep; 2018 Mar; 8(1):4468. PubMed ID: 29535397
[TBL] [Abstract][Full Text] [Related]
9. E2F regulation of the
Zappia MP; Kwon YJ; Westacott A; Liseth I; Lee HM; Islam ABMMK; Kim J; Frolov MV
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2220770120. PubMed ID: 37011211
[TBL] [Abstract][Full Text] [Related]
10. Molecular abnormality of phosphoglycerate kinase-Uppsala associated with chronic nonspherocytic hemolytic anemia.
Fujii H; Yoshida A
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5461-5. PubMed ID: 6933565
[TBL] [Abstract][Full Text] [Related]
11. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
[TBL] [Abstract][Full Text] [Related]
12. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic heterogeneity of phosphoglycerate kinase (PGK) deficiency.
Tsujino S; Shanske S; DiMauro S
Muscle Nerve Suppl; 1995; 3():S45-9. PubMed ID: 7603527
[TBL] [Abstract][Full Text] [Related]
14. Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.
Morales-Briceño H; Ha AD; London K; Farlow D; Chang FCF; Fung VSC
Parkinsonism Relat Disord; 2019 Jul; 64():319-323. PubMed ID: 30975619
[TBL] [Abstract][Full Text] [Related]
15. Novel Drosophila model for mitochondrial diseases by targeting of a solute carrier protein SLC25A46.
Suda K; Ueoka I; Azuma Y; Muraoka Y; Yoshida H; Yamaguchi M
Brain Res; 2018 Jun; 1689():30-44. PubMed ID: 29604258
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic and metabolic characterization of the phosphoglycerate kinase deficiency associated with chronic hemolytic anemia caused by the PGK-Barcelona mutation.
Ramírez-Bajo MJ; Repiso A; la Ossa PP; Bañón-Maneus E; de Atauri P; Climent F; Corrons JL; Cascante M; Carreras J
Blood Cells Mol Dis; 2011 Mar; 46(3):206-11. PubMed ID: 21269848
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease.
Koutzoumis DN; Vergara M; Pino J; Buddendorff J; Khoshbouei H; Mandel RJ; Torres GE
Exp Neurol; 2020 Mar; 325():113159. PubMed ID: 31843492
[TBL] [Abstract][Full Text] [Related]
18. Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do
Sakaue S; Kasai T; Mizuta I; Suematsu M; Osone S; Azuma Y; Imamura T; Tokuda T; Kanno H; El-Agnaf OMA; Morimoto M; Nakagawa M; Hosoi H; Mizuno T
NPJ Parkinsons Dis; 2017; 3():13. PubMed ID: 28649613
[TBL] [Abstract][Full Text] [Related]
19. Thiol Oxidation by Diamide Leads to Dopaminergic Degeneration and Parkinsonism Phenotype in Mice: A Model for Parkinson's Disease.
Ray A; Kambali M; Ravindranath V
Antioxid Redox Signal; 2016 Aug; 25(5):252-67. PubMed ID: 27121974
[TBL] [Abstract][Full Text] [Related]
20. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: molecular and functional characterization.
Fermo E; Bianchi P; Chiarelli LR; Maggi M; Mandarà GM; Vercellati C; Marcello AP; Barcellini W; Cortelezzi A; Valentini G; Zanella A
Mol Genet Metab; 2012 Aug; 106(4):455-61. PubMed ID: 22705348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
